A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG).
Elżbieta KalicińskaAgnieszka GizaJan Maciej ZauchaSebastian GiebelDagmara Zimowska-CuryłoIga AndrasiakWojciech SpychałowiczJerzy WojnarAndrzej BalcerzakJoanna Romejko-JarosinskaEwa Paszkiewicz-KozikWanda Knopińska-PosłusznyJustyna RybkaPaula JabłonowskaTomasz WróbelPublished in: Cancer medicine (2022)
Secondary lymphoma accounts for more than half of the orbital lymphoma in Polish population. The advanced clinical stage of the disease (non-IE according to Ann Arbor) concerns two-thirds of the overall population of patients with orbital lymphomas and one-third of MALT lymphoma patients. The high incidence of advanced stages of orbital lymphoma may indicate the need for combined treatment. Combined orbital lymphoma treatment is associated with superior PFS compared to chemotherapy alone in overall population of patients with orbital lymphoma.